Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has 65 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 8,306,063 | 0 | 0.00% | $35,300,768.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 5,037,906 | -89,350 | -1.74% | $21,411,101.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,204,319 | 2,204,319 | 0.00% | $9,368,356.00 |
| Alyeska Investment Group, L.P. | 31 Mar, 2026 | 1,000,000 | 0 | 0.00% | $4,250,000.00 |
| Propel Bio Management, LLC | 31 Mar, 2026 | 896,701 | 896,701 | 0.00% | $3,830,724.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 702,543 | 459,070 | 188.55% | $2,985,808.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 635,714 | 4,813 | 0.76% | $2,701,784.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 485,492 | 12,129 | 2.56% | $2,064,440.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 402,550 | -170,254 | -29.72% | $1,710,838.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 265,499 | 1,711 | 0.65% | $1,128,371.00 |
| Knott David M Jr | 31 Mar, 2026 | 253,651 | 3,651 | 1.46% | $1,078,017.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 235,214 | 235,214 | 0.00% | $999,660.00 |
| Simplify Asset Management Inc. | 31 Mar, 2026 | 219,387 | 219,387 | 0.00% | $932,395.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 188,484 | 16,803 | 9.79% | $801,059.00 |
| 683 Capital Management, LLC | 31 Mar, 2026 | 185,000 | -19,076 | -9.35% | $786,250.00 |
| State Street Corp | 31 Mar, 2026 | 169,410 | 10,377 | 6.53% | $719,993.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 155,242 | -112,904 | -42.11% | $659,779.00 |
| DAFNA Capital Management LLC | 31 Mar, 2026 | 126,841 | 0 | 0.00% | $539,074.00 |
| Northern Trust Corp | 31 Mar, 2026 | 118,274 | 7,375 | 6.65% | $502,665.00 |
| Qube Research & Technologies Ltd | 31 Mar, 2026 | 108,953 | 2,211 | 2.07% | $463,050.00 |